Literature DB >> 36123515

Co-amorphous Drug Delivery Systems: a Review of Physical Stability, In Vitro and In Vivo Performance.

Qin Shi1, Yanan Wang2, Sakib M Moinuddin3,4, Xiaodong Feng3, Fakhrul Ahsan5,6.   

Abstract

Over the past few decades, co-amorphous solids have been used as a promising approach for delivering poorly water-soluble drugs. Co-amorphous solids, comprising pharmacologically relevant drug substances or excipients, improve physical stability, solubility, dissolution, and bioavailability compared with single amorphous ingredients. In this review, we have summarized recent advances in physical stability and in vitro and in vivo performances of co-amorphous solids. We have highlighted the role of molar ratio, molecular interaction, and mobility that affects the physical stability of co-amorphous solids. This review delves deep as to how co-amorphous solids affect the physicochemical properties in vitro and in vivo. We also described the challenges to the formulation of co-amorphous solids. A better understanding of the mechanisms of the physical stability, in vitro and in vivo performance of co-amorphous solids, and proper selection of the co-former is likely to expedite the development of robust co-amorphous-based pharmaceutical formulations and can address the challenges associated with the delivery of poorly soluble drugs.
© 2022. The Author(s), under exclusive licence to American Association of Pharmaceutical Scientists.

Entities:  

Keywords:  co-amorphous solids; in vitro dissolution; in vivo performance; physical stability; supersaturation

Mesh:

Substances:

Year:  2022        PMID: 36123515     DOI: 10.1208/s12249-022-02421-7

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   4.026


  72 in total

Review 1.  Recent advances in co-amorphous drug formulations.

Authors:  Swapnil Jayant Dengale; Holger Grohganz; Thomas Rades; Korbinian Löbmann
Journal:  Adv Drug Deliv Rev       Date:  2016-01-21       Impact factor: 15.470

Review 2.  Considerations for the selection of co-formers in the preparation of co-amorphous formulations.

Authors:  Dani Lakshman Yarlagadda; Vullendula Sai Krishna Anand; Athira R Nair; K S Navya Sree; Swapnil J Dengale; Krishnamurthy Bhat
Journal:  Int J Pharm       Date:  2021-04-27       Impact factor: 5.875

Review 3.  Physical stability of amorphous pharmaceutical solids: Nucleation, crystal growth, phase separation and effects of the polymers.

Authors:  Qin Shi; Fang Li; Stacy Yeh; Yanan Wang; Junbo Xin
Journal:  Int J Pharm       Date:  2020-10-02       Impact factor: 5.875

4.  Drug-Drug Multicomponent Solid Forms: Cocrystal, Coamorphous and Eutectic of Three Poorly Soluble Antihypertensive Drugs Using Mechanochemical Approach.

Authors:  Jamshed Haneef; Renu Chadha
Journal:  AAPS PharmSciTech       Date:  2017-01-18       Impact factor: 3.246

5.  Acceleration of Crystal Growth of Amorphous Griseofulvin by Low-Concentration Poly(ethylene oxide): Aspects of Crystallization Kinetics and Molecular Mobility.

Authors:  Qin Shi; Chen Zhang; Yuan Su; Jie Zhang; Dongshan Zhou; Ting Cai
Journal:  Mol Pharm       Date:  2017-06-07       Impact factor: 4.939

Review 6.  Recent Advances in Enhancement of Dissolution and Supersaturation of Poorly Water-Soluble Drug in Amorphous Pharmaceutical Solids: A Review.

Authors:  Qin Shi; Fang Li; Stacy Yeh; Sakib M Moinuddin; Junbo Xin; Jia Xu; Hao Chen; Bai Ling
Journal:  AAPS PharmSciTech       Date:  2021-12-10       Impact factor: 3.246

7.  Co-Amorphous Formation of Simvastatin-Ezetimibe: Enhanced Physical Stability, Bioavailability and Cholesterol-Lowering Effects in LDLr-/-Mice.

Authors:  Shamuha Bahetibieke; Sakib M Moinuddin; Asiya Baiyisaiti; Xiaoang Liu; Jie Zhang; Guomin Liu; Qin Shi; Ankang Peng; Jun Tao; Chang Di; Ting Cai; Rong Qi
Journal:  Pharmaceutics       Date:  2022-06-13       Impact factor: 6.525

8.  Advances in coamorphous drug delivery systems.

Authors:  Qin Shi; Sakib M Moinuddin; Ting Cai
Journal:  Acta Pharm Sin B       Date:  2018-08-16       Impact factor: 11.413

Review 9.  Insoluble drug delivery strategies: review of recent advances and business prospects.

Authors:  Sandeep Kalepu; Vijaykumar Nekkanti
Journal:  Acta Pharm Sin B       Date:  2015-08-24       Impact factor: 11.413

Review 10.  Co-Amorphous Drug Formulations in Numbers: Recent Advances in Co-Amorphous Drug Formulations with Focus on Co-Formability, Molar Ratio, Preparation Methods, Physical Stability, In Vitro and In Vivo Performance, and New Formulation Strategies.

Authors:  Jingwen Liu; Holger Grohganz; Korbinian Löbmann; Thomas Rades; Nele-Johanna Hempel
Journal:  Pharmaceutics       Date:  2021-03-15       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.